A Johnson & Johnson subsidiary asked a New Jersey appeals court Feb. 23 to overturn an $11.1 million verdict awarded in the first bellwether trial over allegedly harmful pelvic mesh implants.

Charles Lifland, representing the subsidiary, Ethicon, acknowledged that the plaintiff sustained serious injuries as a result of having the implant and that the company was “sympathetic” to the plaintiff, but added that the verdict should not be allowed to stand.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]